Project Grant R43DP006691

The Department of Health and Human Services Centers for Disease Control and Prevention (CDC) awarded a $1,836,678 project grant under the Prevention of Disease, Disability, and Death by Infectious Diseases (CFDA 93.084) program to Empowerx, Inc. The grant, titled "HORMONAL CONTRACEPTIVE ACCESS VIA PHARMACIST-PRESCRIBING IMPLEMENTATION PACKAGE (HAPPI)", aims to develop and implement a package to increase access to hormonal contraceptives through pharmacist-prescribing. The project...

This federal Project Grant award for $393,142.00 from the National Institute of Child Health and Human Development (NICHD), under the Child Health and Human Development Extramural Research program (CFDA 93.865), aims to explore the synergies between pharmacy-based delivery of HIV pre-exposure prophylaxis (PrEP) and contraception services for adolescent girls and young women (AGYW) in Kenya. The key products and services to be delivered under this award include: A cluster randomized clinical...

This Project Grant award from the National Institute of Child Health and Human Development (CFDA 93.865 - Child Health and Human Development Extramural Research) provides $474,946 to the University of Health Sciences and Pharmacy in St. Louis to develop a novel, non-hormonal contraceptive device. The project aims to create a dual-compartment vaginal device that enables women to self-administer a contraceptive polymer fiber mat and supplemental fluid to form a biorespon-sive, acid-buffering,...

This Project Grant award from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242) provides $1,554,880 to Yale University to expand and integrate a pre-exposure prophylaxis (PrEP) decision aid into contraceptive counseling visits at sexual and reproductive health clinics in the New Haven, CT area. The purpose is to increase PrEP access and use among cisgender women, who have a high unmet need for PrEP despite available resources. The...

This $262,627 Project Grant award from the National Institute of Mental Health (CFDA 93.242 Mental Health Research Grants) supports the development and testing of a novel peer navigator mHealth intervention to increase uptake of pre-exposure prophylaxis (PrEP) and modern contraception among female university students in Zambia. The key products and services to be delivered under this grant include: Adapting an existing app, PEBRA, using human-centered design and qualitative methods to create a...

This federal Project Grant award from the National Institute of Child Health and Human Development (NICHD), under the Child Health and Human Development Extramural Research program (CFDA 93.865), is providing $573,475 to The Botswana Harvard Health Partnership (BHP) to conduct a randomized trial evaluating the effect of integrating sexually transmitted infection (STI) testing with expanded pre-exposure prophylaxis (PrEP) options on PrEP use among pregnant women in Botswana. The study aims to...

The National Institute of Child Health and Human Development (NICHD) awarded a $518,754 Project Grant under the Child Health and Human Development Extramural Research program (CFDA 93.865) to the Magee-Womens Research Institute and Foundation. The grant will fund the development of an extended-release vaginal film that combines a contraceptive monoclonal antibody (MAb) with anti-HIV and anti-HSV MAbs to provide protection against unintended pregnancy and sexually transmitted infections for up to...

This Project Grant award from the National Institute of Child Health and Human Development (NICHD), under the Child Health and Human Development Extramural Research program (CFDA 93.865), provides $781,926 to Emory University to develop and pilot test an innovative intervention to improve postpartum family planning (PPFP) services in Zambia. The key activities include conducting formative research to evaluate structural, contextual, individual, and couple-level factors influencing healthy...

This $283,625 Project Grant award from the National Institutes of Health (NIH) Trans-NIH Research Support program (CFDA 93.310) aims to increase pre-exposure prophylaxis (PrEP) access and use among cisgender Black women (CBW) in Houston, Texas. The primary objectives are to: 1) increase willingness to access and use PrEP among CBW, and 2) increase willingness of healthcare providers to prescribe and refer PrEP to CBW. The project will explore the feasibility, acceptability, and preliminary...

This Project Grant award from the National Institute of Child Health and Human Development (NICHD), under the Child Health and Human Development Extramural Research program (CFDA 93.865), provides $380,692 to Mucommune LLC to develop and validate an ultrapotent anti-sperm antibody construct for a non-hormonal contraceptive intravaginal ring (IVR). The research aims to formulate the next-generation antibody (LAMH10) into the IVR, characterize its release kinetics and activity, and evaluate the...